Prospective phase II study of allogeneic hematopoietic stem cell transplantation with targeted busulfan, fludarabine, and etoposide conditioning in pediatric acute lymphoblastic leukemia

被引：0
|
作者：
Hong, Kyung Taek [1 ,2 ]
Park, Hyun Jin [1 ,2 ]
Kim, Bo Kyung [1 ,2 ]
Choi, Jung Yoon [1 ,2 ]
Song, Sang Hoon [3 ]
Lee, Seunghwan [4 ]
Yu, Kyung-Sang [4 ]
Jang, In-Jin [4 ]
Kang, Hyoung Jin [1 ,2 ,5 ]
机构：
[1] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul Natl Univ Childrens Hosp, Seoul, South Korea
[2] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea
[4] Seoul Natl Univ, Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South Korea
[5] Wide River Inst Immunol, Hongcheon, South Korea
来源：
HEMASPHERE | 2024年 / 8卷 / 12期
关键词：
TOTAL-BODY IRRADIATION; DAILY INTRAVENOUS BUSULFAN; CHILDHOOD; CHEMOTHERAPY; CHILDREN; REMISSION; REGIMENS; HSCT;
D O I：
10.1002/hem3.70051
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia
    Lee, Seung-Shin
    Jung, Sung-Hoon
    Do, Young Rok
    Kim, Dae Sik
    Lee, Ji Hyun
    Park, Han-Seung
    Moon, Joon Ho
    Yi, Jun Ho
    Park, Yong
    Koh, Youngil
    Yhim, Ho-Young
    Choi, Yunsuk
    Mun, Yeung-Chul
    Lee, Won-Sik
    Lee, Seok
    Yang, Deok-Hwan
    YONSEI MEDICAL JOURNAL, 2020, 61 (06) : 452 - 459
  • [2] Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells
    Bornhäuser, M
    Storer, B
    Slattery, JT
    Appelbaum, FR
    Deeg, HJ
    Hansen, J
    Martin, PJ
    McDonald, GB
    Nichols, WG
    Radich, J
    Woolfrey, A
    Jenke, A
    Schleyer, E
    Thiede, C
    Ehninger, G
    Anasetti, C
    BLOOD, 2003, 102 (03) : 820 - 826
  • [3] Prospective Phase II Study of HSCT Using Targeted Busulfan, Fludarabine, Etoposide Conditioning for Pediatric ALL
    Hong, Kyung Taek
    Park, Hyun Jin
    Kim, Bo Kyung
    An, Hong Yul
    Choi, Jung Yoon
    Kang, Hyoung Jin
    BLOOD, 2022, 140 : 4716 - 4717
  • [4] Targeted Intravenous Busulfan and Fludarabine Allogeneic Transplantation Conditioning in Acute Myeloid Leukemia
    Pidala, Joseph A.
    Kim, Jongphil
    Anasetti, Claudio
    Alsina, Melissa
    Ayala, Ernesto
    Field, Teresa
    Kharfan-Dabaja, Mohamed A.
    Ochoa, Jose L.
    Perez, Lia
    Perkins, Janelle
    Tomblyn, Marcie
    Fernandez, Hugo F.
    BLOOD, 2009, 114 (22) : 904 - 904
  • [5] Conditioning with fludarabine and targeted busulfan before transplantation of allogeneic hematopoietic stem cells.
    Bornhaeuser, M
    Storer, B
    Slattery, JT
    Appelbaum, FR
    Deeg, HJ
    Hansen, J
    McDonald, G
    Martin, PJ
    Nichols, G
    Radich, J
    Woolfrey, A
    Schleyer, E
    Jenke, A
    Thiede, C
    Ehninger, G
    Anasetti, C
    BLOOD, 2002, 100 (11) : 213A - 213A
  • [6] Fludarabine and Targeted Busulfan Is Safe and Effective Conditioning Before Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia in First Remission
    Kunter, Ghada M.
    Perkins, Janelle
    Perez, Lia
    Pidala, Joseph
    Field, Teresa
    Tomblyn, Marcie
    Fernandez, Hugo F.
    Anasetti, Claudio
    BLOOD, 2011, 118 (21) : 407 - 407
  • [7] Allogeneic hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia
    Tian, Jieyu
    Wei, Ang
    Wang, Bin
    Yang, Jun
    Zheng, Huyong
    Qin, Maoquan
    ANNALS OF HEMATOLOGY, 2024, 103 (01) : 297 - 305
  • [8] Busulfan-containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study
    Wang, Yu-Hung
    Tien, Feng-Ming
    Tsai, Cheng-Hong
    Huang, Huai-Hsuan
    Liu, Jia-Hau
    Liao, Xiu-Wen
    Tang, Jih-Luh
    Yao, Ming
    Ko, Bor-Sheng
    CANCER REPORTS, 2022, 5 (03)
  • [9] OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION IN PEDIATRIC PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER CONDITIONING WITH BUSULFAN, CYCLOPHOSPHAMIDE, AND ETOPOSIDE
    Ayas, Mouhab
    Belgaumi, Assim
    Al-Seraihy, Amal
    Al-Jefri, Abdullah
    Al-Ahmari, Ali
    Al-Mahr, Mohammed
    Khairy, Ashraf
    Markiz, Samer
    El-Soth, Hassan
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 816 - 816
  • [10] Fludarabine and busulfan as a reduced-toxicity myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation for acute leukemia patients
    Dai, Zhiming
    Liu, Jie
    Zhang, Wang-Gang
    Cao, Xingmei
    Zhang, Yang
    Dai, Zhijun
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (04) : 667 - 671
12345